SCHEMBL236793

SCHEMBL236793

CC(CC#N)SC(=S)c1cc(C#N)cc(C#N)c1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TTR P02766 1/20 0.32
ALB P02768 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL238446 0.84 MEN1 (0.39)
SCHEMBL2791417 0.77 MAOB (0.36)
SCHEMBL233980 0.73 TTR (0.37) TTRALB
SCHEMBL234054 0.70
SCHEMBL8738821 0.66 TTR (0.34) TTRALB
SCHEMBL9918190 0.63 GLA (0.33) TTRALB
SCHEMBL23600062 0.63 GSK3B (0.43)
SCHEMBL17267372 0.63 MEN1 (0.41)
SCHEMBL30616790 0.62 MGLL (0.38)
SCHEMBL16678185 0.62 GSK3B (0.44) TTRALB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9745406-B2 Curable composition CEMEDINE CO., LTD. (JP) 2017-08-29 US disclosed
EP-2412756-B1 CURABLE COMPOSITION CEMEDINE CO LTD (JP) 2016-12-21 EP disclosed
EP-2412756-A1 CURABLE COMPOSITION CEMEDINE CO., LTD. (JP) 2012-02-01 EP disclosed
US-20120004371-A1 CURABLE COMPOSITION CEMEDINE CO., LTD. (JP) 2012-01-05 US disclosed